You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 00641-6053


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00641-6053

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
MEPERIDINE HCL 50MG/ML INJ Hikma Pharmaceuticals USA Inc. 00641-6053-25 25X1ML 53.77 2021-08-15 - 2026-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00641-6053 Market Analysis and Financial Projection

Market Analysis and Price Projections for Meperidine Hydrochloride Injection (NDC: 00641-6053)

Overview of Meperidine Hydrochloride Injection

Meperidine Hydrochloride Injection, with the NDC code 00641-6053, is a prescription drug used for preoperative medication, support of anesthesia, and obstetrical analgesia. It is classified as a Schedule CII controlled substance due to its potential for abuse and dependency[5].

Market Size and Growth

The meperidine drugs market, which includes Meperidine Hydrochloride Injection, is anticipated to experience steady growth. Here are some key points:

  • Growth Rate: The meperidine drugs market is expected to register a Compound Annual Growth Rate (CAGR) of approximately 4.1% during the forecast period from 2020 to 2025[1].
  • Regional Dominance: North America holds the largest share in the market, driven by a significant number of surgical procedures and increasing incidence of pain-related disorders in the U.S.[1].
  • Emerging Markets: The Asia-Pacific region is expected to witness the fastest growth due to increasing volumes of dental and cosmetic surgeries, advancements in surgical procedures, and growing use of meperidine in post-operative pain management[1].

Applications and Demand Drivers

Pain Relief and Surgical Procedures

Meperidine Hydrochloride Injection is widely used for pain relief, including headaches, muscle strain, bruising, and arthritis. The demand is driven by:

  • Geriatric Population: The increasing geriatric population is a significant factor, as this demographic often requires more pain relief solutions[1].
  • Cost Efficiency: The cost efficiency of over-the-counter (OTC) analgesics and meperidine drugs contributes to their growing demand[1].
  • Technological Advancements: Improvements in drug delivery systems also play a crucial role in the market growth[1].

Preoperative and Obstetrical Use

  • Preoperative Medication: Meperidine is used 30 to 90 minutes before beginning anesthesia to help manage pain and anxiety[5].
  • Obstetrical Analgesia: It is used to provide pain relief during labor and delivery[5].

Price Projections and Factors Influencing Pricing

Current Pricing and Availability

  • Current Availability: Despite occasional shortages, all marketed presentations of Meperidine Hydrochloride Injection are generally available[2].
  • Price Variability: Retail prices for meperidine and other drugs can vary significantly depending on the source and editing rules applied to the data. For instance, prices in the MEPS (Medical Expenditure Panel Survey) data are often lower compared to MarketScan data, but editing rules can align these prices more closely[4].

Future Pricing Trends

  • Regulatory and Market Factors: The pricing of meperidine drugs can be influenced by regulatory changes, technological advancements, and market competition. As the biopharma and biotech industries evolve, there may be shifts in pricing strategies to reflect new innovations and patient-centered care approaches[3].
  • Cost of Production and Distribution: The cost of producing and distributing meperidine drugs, including raw materials and manufacturing processes, will continue to impact pricing.
  • Demand and Supply Dynamics: The balance between demand driven by surgical procedures and the supply of meperidine drugs will also influence price stability or fluctuations.

Challenges and Limitations

Abuse and Dependency

One of the significant challenges facing the meperidine drugs market is the potential for abuse and dependency. This can lead to regulatory scrutiny and public health concerns, which may impact market growth[1].

Side Effects and Alternatives

  • Side Effects: Meperidine Hydrochloride Injection can cause side effects such as respiratory depression, especially when initiating or increasing doses. This may lead to a search for alternative pain management options[5].
  • Alternative Therapies: The development of new pain management therapies could potentially reduce the demand for meperidine drugs.

Regional Market Analysis

North America

  • Market Share: North America currently holds the largest share in the meperidine drugs market, primarily due to the high number of surgical procedures performed in the U.S.[1].
  • Growth Drivers: Increasing incidence of pain-related disorders and escalating healthcare expenditures are key drivers in this region[1].

Asia-Pacific

  • Fastest Growing Market: The Asia-Pacific region is expected to witness the fastest growth, driven by increasing volumes of dental and cosmetic surgeries and advancements in surgical procedures[1].
  • Geriatric Population: The expanding geriatric population in this region is also a significant factor contributing to market growth[1].

Key Takeaways

  • The meperidine drugs market is expected to grow at a CAGR of 4.1% from 2020 to 2025.
  • North America dominates the market, while the Asia-Pacific region is expected to be the fastest-growing market.
  • Demand is driven by the geriatric population, cost efficiency, and technological advancements in drug delivery systems.
  • Pricing is influenced by regulatory factors, market competition, and demand-supply dynamics.
  • Challenges include potential for abuse and dependency, side effects, and the development of alternative therapies.

FAQs

What is the primary use of Meperidine Hydrochloride Injection?

Meperidine Hydrochloride Injection is primarily used for preoperative medication, support of anesthesia, and obstetrical analgesia.

What is the expected growth rate of the meperidine drugs market?

The meperidine drugs market is expected to register a CAGR of approximately 4.1% during the forecast period from 2020 to 2025.

Which region dominates the meperidine drugs market?

North America currently holds the largest share in the meperidine drugs market.

What are the key drivers of demand for meperidine drugs?

Key drivers include the increasing geriatric population, cost efficiency of OTC analgesics, and technological advancements in drug delivery systems.

What are the potential challenges facing the meperidine drugs market?

Challenges include the potential for abuse and dependency, side effects such as respiratory depression, and the development of alternative pain management therapies.

How does the pricing of meperidine drugs vary?

Pricing can vary based on regulatory factors, market competition, and demand-supply dynamics, as well as differences in data sources and editing rules.

Sources

  1. Mordor Intelligence: Meperidine Drugs Market Size & Share Analysis - Growth Trends
  2. Drugs.com: Meperidine Hydrochloride Injection Shortage
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025
  4. MEPS: Comparison of Retail Drug Prices in the MEPS and MarketScan
  5. DailyMed: Label: Meperidine Hydrochloride injection

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.